Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 0.570-0.630 for the period, compared to the consensus earnings per share estimate of 0.610. The company issued revenue guidance of $2.7 billion-$2.8 billion, compared to the consensus revenue estimate of $2.7 billion.
Amneal Pharmaceuticals Stock Performance
Shares of AMRX stock opened at $7.65 on Friday. The company has a debt-to-equity ratio of 121.31, a quick ratio of 0.97 and a current ratio of 1.65. The stock has a market cap of $2.36 billion, a PE ratio of -13.66 and a beta of 1.23. Amneal Pharmaceuticals has a 1 year low of $3.36 and a 1 year high of $8.15. The stock has a fifty day moving average price of $6.97 and a 200 day moving average price of $6.29.
Wall Street Analysts Forecast Growth
AMRX has been the subject of a number of research reports. The Goldman Sachs Group lifted their target price on shares of Amneal Pharmaceuticals from $6.25 to $8.00 and gave the stock a buy rating in a research report on Monday, May 6th. Truist Financial reiterated a buy rating and set a $9.00 target price (up previously from $7.00) on shares of Amneal Pharmaceuticals in a report on Monday, May 6th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, Amneal Pharmaceuticals has an average rating of Buy and a consensus target price of $8.25.
About Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc, together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment offers immediate and extended release oral solid, powder, liquid, sterile injectable, nasal spray, inhalation and respiratory, biosimilar, ophthalmic, film, transdermal patch, and topical products.
Read More
- Five stocks we like better than Amneal Pharmaceuticals
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- How to Invest in Insurance Companies: A Guide
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- CD Calculator: Certificate of Deposit Calculator
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
